CD40 and cancer: Among the 23 cancer types screened, CD40 downregulation was observed in 11 malignancies compared to corresponding normal tissues, including brain, breast, lung, colon, ovary, esophagus, skin, prostate, uterus, endometrium, and blood cancers.